{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:16:03Z","timestamp":1783120563585,"version":"3.54.6"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02756"],"award-info":[{"award-number":["18H02756"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07501"],"award-info":[{"award-number":["21K07501"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H04791 and 21H051130"],"award-info":[{"award-number":["21H04791 and 21H051130"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"MEXT | Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["PMJFR215T and JPMJMS2023"],"award-info":[{"award-number":["PMJFR215T and JPMJMS2023"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21gm0010004h9905"],"award-info":[{"award-number":["21gm0010004h9905"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prototypic antidepressants, such as tricyclic\/tetracyclic antidepressants (TCAs), have multiple pharmacological properties and have been considered to be more effective than newer antidepressants, such as selective serotonin reuptake inhibitors, in treating severe depression. However, the clinical contribution of non-monoaminergic effects of TCAs remains elusive. In this study, we discovered that amitriptyline, a typical TCA, directly binds to the lysophosphatidic acid receptor 1 (LPAR1), a G protein-coupled receptor, and activates downstream G protein signaling, while exerting a little effect on \u03b2-arrestin recruitment. This suggests that amitriptyline acts as a G protein-biased agonist of LPAR1. This biased agonism was specific to TCAs and was not observed with other antidepressants. LPAR1 was found to be involved in the behavioral effects of amitriptyline. Notably, long-term infusion of mouse hippocampus with the potent G protein-biased LPAR agonist OMPT, but not the non-biased agonist LPA, induced antidepressant-like behavior, indicating that G protein-biased agonism might be necessary for the antidepressant-like effects. Furthermore, RNA-seq analysis revealed that LPA and OMPT have opposite patterns of gene expression changes in the hippocampus. Pathway analysis indicated that long-term treatment with OMPT activated LPAR1 downstream signaling (Rho and MAPK), whereas LPA suppressed LPAR1 signaling. Our findings provide insights into the mechanisms underlying the non-monoaminergic antidepressant effects of TCAs and identify the G protein-biased agonism of LPAR1 as a promising target for the development of novel antidepressants.<\/jats:p>","DOI":"10.1038\/s41386-023-01727-9","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:02:08Z","timestamp":1693998128000},"page":"561-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression"],"prefix":"10.1038","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-9206","authenticated-orcid":false,"given":"Naoto","family":"Kajitani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Okada-Tsuchioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-4049","authenticated-orcid":false,"given":"Asuka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Miyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuken","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1780-692X","authenticated-orcid":false,"given":"Kazuya","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Uezono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-1896","authenticated-orcid":false,"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Takebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366.","journal-title":"Lancet."},{"key":"1727_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","volume":"58","author":"IM Anderson","year":"2000","unstructured":"Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19\u201336.","journal-title":"J Affect Disord"},{"key":"1727_CR3","doi-asserted-by":"publisher","first-page":"27364","DOI":"10.1074\/jbc.M116.753871","volume":"291","author":"N Kajitani","year":"2016","unstructured":"Kajitani N, Miyano K, Okada-Tsuchioka M, Abe H, Itagaki K, Hisaoka-Nakashima K, et al. Identification of lysophosphatidic acid receptor 1 in Astroglial Cells as a target for Glial cell line-derived neurotrophic factor expression induced by antidepressants. J Biol Chem. 2016;291:27364\u201370.","journal-title":"J Biol Chem"},{"key":"1727_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1124\/jpet.116.236455","volume":"359","author":"MC Olianas","year":"2016","unstructured":"Olianas MC, Dedoni S, Onali P. LPA1 mediates antidepressant-induced ERK1\/2 signaling and protection from oxidative stress in glial cells. J Pharmacol Exp Ther. 2016;359:340\u201353.","journal-title":"J Pharmacol Exp Ther"},{"key":"1727_CR5","doi-asserted-by":"publisher","first-page":"174986","DOI":"10.1016\/j.ejphar.2022.174986","volume":"925","author":"N Tokunaga","year":"2022","unstructured":"Tokunaga N, Takimoto T, Nakamura Y, Hisaoka-Nakashima K, Morioka N. Downregulation of connexin 43 potentiates amitriptyline-induced brain-derived neurotrophic factor expression in primary astrocytes through lysophosphatidic acid receptor1\/3, Src, and extracellular signal-regulated kinase. Eur J Pharmacol. 2022;925:174986.","journal-title":"Eur J Pharmacol"},{"key":"1727_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/1570159X15666170710200352","volume":"16","author":"RD Moreno-Fernandez","year":"2018","unstructured":"Moreno-Fernandez RD, Tabbai S, Castilla-Ortega E, Perez-Martin M, Estivill-Torrus G, Rodriguez de Fonseca F, et al. Stress, depression, resilience and ageing: a role for the LPA-LPA1 pathway. Curr Neuropharmacol. 2018;16:271\u201383.","journal-title":"Curr Neuropharmacol"},{"key":"1727_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.24","volume":"7","author":"RD Moreno-Fern\u00e1ndez","year":"2017","unstructured":"Moreno-Fern\u00e1ndez RD, P\u00e9rez-Mart\u00edn M, Castilla-Ortega E, Rosell Del Valle C, Garc\u00eda-Fern\u00e1ndez MI, Chun J, et al. maLPA1-null mice as an endophenotype of anxious depression. Transl Psychiatry. 2017;7:e1077.","journal-title":"Transl Psychiatry"},{"key":"1727_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00429-021-02261-4","volume":"226","author":"C Rosell-Valle","year":"2021","unstructured":"Rosell-Valle C, Mart\u00ednez-Losa M, Matas-Rico E, Castilla-Ortega E, Zambrana-Infantes E, G\u00f3mez-Conde AI, et al. GABAergic deficits in absence of LPA1 receptor, associated anxiety-like and coping behaviors, and amelioration by interneuron precursor transplants into the dorsal hippocampus. Brain Struct Funct. 2021;226:1479\u201395.","journal-title":"Brain Struct Funct"},{"key":"1727_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00702-014-1289-9","volume":"122","author":"M Yamada","year":"2015","unstructured":"Yamada M, Tsukagoshi M, Hashimoto T, Oka J, Saitoh A. Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice. J Neural Transm (Vienna). 2015;122:487\u201394.","journal-title":"J Neural Transm (Vienna)"},{"key":"1727_CR10","doi-asserted-by":"publisher","first-page":"e85348","DOI":"10.1371\/journal.pone.0085348","volume":"9","author":"E Castilla-Ortega","year":"2014","unstructured":"Castilla-Ortega E, Escuredo L, Bilbao A, Pedraza C, Orio L, Estivill-Torr\u00fas G, et al. 1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats. PLoS One. 2014;9:e85348.","journal-title":"PLoS One"},{"key":"1727_CR11","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1242\/jcs.02634","volume":"118","author":"NM Urs","year":"2005","unstructured":"Urs NM, Jones KT, Salo PD, Severin JE, Trejo J, Radhakrishna H. A requirement for membrane cholesterol in the beta-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors. J Cell Sci. 2005;118:5291\u2013304.","journal-title":"J Cell Sci"},{"key":"1727_CR12","doi-asserted-by":"publisher","first-page":"107404","DOI":"10.1016\/j.pharmthera.2019.107404","volume":"204","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Little PJ, Ta HT, Xu S, Kamato D. Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease. Pharmacol Ther. 2019;204:107404.","journal-title":"Pharmacol Ther"},{"key":"1727_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.106.104463","volume":"320","author":"JD Urban","year":"2007","unstructured":"Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, et al. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther. 2007;320:1\u201313.","journal-title":"J Pharmacol Exp Ther"},{"key":"1727_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41589-021-00930-3","volume":"18","author":"Z Xu","year":"2022","unstructured":"Xu Z, Ikuta T, Kawakami K, Kise R, Qian Y, Xia R, et al. Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism. Nat Chem Biol. 2022;18:281\u20138.","journal-title":"Nat Chem Biol"},{"key":"1727_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.33","volume":"5","author":"H Mirendil","year":"2015","unstructured":"Mirendil H, Thomas EA, De Loera C, Okada K, Inomata Y, Chun J. LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage. Transl Psychiatry. 2015;5:e541.","journal-title":"Transl Psychiatry"},{"key":"1727_CR16","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/nmeth.2172","volume":"9","author":"A Inoue","year":"2012","unstructured":"Inoue A, Ishiguro J, Kitamura H, Arima N, Okutani M, Shuto A, et al. TGF\u03b1 shedding assay: an accurate and versatile method for detecting GPCR activation. Nat Methods. 2012;9:1021\u20139.","journal-title":"Nat Methods"},{"key":"1727_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07094-0","volume":"9","author":"W Shihoya","year":"2018","unstructured":"Shihoya W, Izume T, Inoue A, Yamashita K, Kadji FMN, Hirata K, et al. Crystal structures of human ETB receptor provide mechanistic insight into receptor activation and partial activation. Nat Commun. 2018;9:4711.","journal-title":"Nat Commun"},{"key":"1727_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4179-2","volume":"12","author":"W Su","year":"2019","unstructured":"Su W, Sun J, Shimizu K, Kadota K. TCC-GUI: a Shiny-based application for differential expression analysis of RNA-Seq count data. BMC Res Notes. 2019;12:133.","journal-title":"BMC Res Notes"},{"key":"1727_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010;327:1345\u201350.","journal-title":"Science."},{"key":"1727_CR20","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/leu.2012.119","volume":"26","author":"A Lopez-Girona","year":"2012","unstructured":"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, et al. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia. 2012;26:2326\u201335.","journal-title":"Leukemia."},{"key":"1727_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/jps.2600790403","volume":"79","author":"K Miyake","year":"1990","unstructured":"Miyake K, Fukuchi H, Kitaura T, Kimura M, Sarai K, Nakahara T. Pharmacokinetics of amitriptyline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline. J Pharm Sci. 1990;79:288\u201391.","journal-title":"J Pharm Sci"},{"key":"1727_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00470582","volume":"78","author":"RK Glotzbach","year":"1982","unstructured":"Glotzbach RK, Preskorn SH. Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats. Psychopharmacology (Berl). 1982;78:25\u20137.","journal-title":"Psychopharmacology (Berl)"},{"key":"1727_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0893-133X(00)00116-0","volume":"23","author":"NR Bolo","year":"2000","unstructured":"Bolo NR, Hod\u00e9 Y, N\u00e9d\u00e9lec JF, Lain\u00e9 E, Wagner G, Macher JP. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology. 2000;23:428\u201338.","journal-title":"Neuropsychopharmacology."},{"key":"1727_CR24","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","volume":"177","author":"A Inoue","year":"2019","unstructured":"Inoue A, Raimondi F, Kadji FMN, Singh G, Kishi T, Uwamizu A, et al. Illuminating G-Protein-Coupling Selectivity of GPCRs. Cell. 2019;177:1933\u201347.e25.","journal-title":"Cell."},{"key":"1727_CR25","first-page":"981","volume":"289","author":"FJ Ehlert","year":"1999","unstructured":"Ehlert FJ, Griffin MT, Sawyer GW, Bailon R. A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells. J Pharmacol Exp Ther. 1999;289:981\u201392.","journal-title":"J Pharmacol Exp Ther"},{"key":"1727_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","volume":"177","author":"B Petit-Demouliere","year":"2005","unstructured":"Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology. 2005;177:245\u201355.","journal-title":"Psychopharmacology"},{"key":"1727_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jneumeth.2010.12.015","volume":"195","author":"TJ Mezadri","year":"2011","unstructured":"Mezadri TJ, Batista GM, Portes AC, Marino-Neto J, Lino-de-Oliveira C. Repeated rat-forced swim test: reducing the number of animals to evaluate gradual effects of antidepressants. J Neurosci Methods. 2011;195:200\u20135.","journal-title":"J Neurosci Methods"},{"key":"1727_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881112467090","volume":"27","author":"LT Yi","year":"2013","unstructured":"Yi LT, Li J, Liu Q, Geng D, Zhou YF, Ke XQ, et al. Antidepressant-like effect of oleanolic acid in mice exposed to the repeated forced swimming test. J Psychopharmacol. 2013;27:459\u201368.","journal-title":"J Psychopharmacol"},{"key":"1727_CR29","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.1073\/pnas.97.24.13384","volume":"97","author":"JJ Contos","year":"2000","unstructured":"Contos JJ, Fukushima N, Weiner JA, Kaushal D, Chun J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA. 2000;97:13384\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1727_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbrc.2020.05.068","volume":"531","author":"N Kajitani","year":"2020","unstructured":"Kajitani N, Okada-Tsuchioka M, Kano K, Omori W, Boku S, Aoki J, et al. Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain. Biochem Biophys Res Commun. 2020;531:89\u201395.","journal-title":"Biochem Biophys Res Commun"},{"key":"1727_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/mp.2011.87","volume":"17","author":"A Bacq","year":"2012","unstructured":"Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, et al. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry. 2012;17:926\u201339.","journal-title":"Mol Psychiatry"},{"key":"1727_CR32","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1242\/jcs.00397","volume":"116","author":"MM Murph","year":"2003","unstructured":"Murph MM, Scaccia LA, Volpicelli LA, Radhakrishna H. Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1\/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway. J Cell Sci. 2003;116:1969\u201380.","journal-title":"J Cell Sci"},{"key":"1727_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27903-2","volume":"8","author":"KM Cahill","year":"2018","unstructured":"Cahill KM, Huo Z, Tseng GC, Logan RW, Seney ML. Improved identification of concordant and discordant gene expression signatures using an updated rank-rank hypergeometric overlap approach. Sci Rep. 2018;8:9588.","journal-title":"Sci Rep"},{"key":"1727_CR34","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1093\/nar\/gkq636","volume":"38","author":"SB Plaisier","year":"2010","unstructured":"Plaisier SB, Taschereau R, Wong JA, Graeber TG. Rank-rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures. Nucleic Acids Res. 2010;38:e169.","journal-title":"Nucleic Acids Res"},{"key":"1727_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard J, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523\u201330.","journal-title":"Bioinformatics."},{"key":"1727_CR36","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1194\/jlr.R046458","volume":"55","author":"YC Yung","year":"2014","unstructured":"Yung YC, Stoddard NC, Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res. 2014;55:1192\u2013214.","journal-title":"J Lipid Res"},{"key":"1727_CR37","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780\u201391.","journal-title":"Cell."},{"key":"1727_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.biopsych.2016.06.012","volume":"81","author":"RC Bagot","year":"2017","unstructured":"Bagot RC, Cates HM, Purushothaman I, Vialou V, Heller EA, Yieh L, et al. Ketamine and Imipramine reverse transcriptional signatures of susceptibility and induce resilience-specific gene expression profiles. Biol Psychiatry. 2017;81:285\u201395.","journal-title":"Biol Psychiatry"},{"key":"1727_CR39","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.4088\/JCP.09r05259gre","volume":"71","author":"G Salvadore","year":"2010","unstructured":"Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA. The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry. 2010;71:1488\u2013501.","journal-title":"J Clin Psychiatry"},{"key":"1727_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/sj.npp.1301399","volume":"33","author":"KA Holick","year":"2008","unstructured":"Holick KA, Lee DC, Hen R, Dulawa SC. Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology. 2008;33:406\u201317.","journal-title":"Neuropsychopharmacology."},{"key":"1727_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.euroneuro.2008.09.002","volume":"19","author":"NN Karpova","year":"2009","unstructured":"Karpova NN, Lindholm J, Pruunsild P, Timmusk T, Castr\u00e9n E. Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol. 2009;19:97\u2013108.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1727_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.pbb.2010.09.010","volume":"97","author":"M Razzoli","year":"2011","unstructured":"Razzoli M, Carboni L, Andreoli M, Michielin F, Ballottari A, Arban R. Strain-specific outcomes of repeated social defeat and chronic fluoxetine treatment in the mouse. Pharmacol Biochem Behav. 2011;97:566\u201376.","journal-title":"Pharmacol Biochem Behav"},{"key":"1727_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.neuropharm.2011.08.045","volume":"62","author":"JL Ihne","year":"2012","unstructured":"Ihne JL, Fitzgerald PJ, Hefner KR, Holmes A. Pharmacological modulation of stress-induced behavioral changes in the light\/dark exploration test in male C57BL\/6\u2009J mice. Neuropharmacology. 2012;62:464\u201373.","journal-title":"Neuropharmacology."},{"key":"1727_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00213-003-1518-7","volume":"170","author":"BJ Caldarone","year":"2003","unstructured":"Caldarone BJ, Karthigeyan K, Harrist A, Hunsberger JG, Wittmack E, King SL, et al. Sex differences in response to oral amitriptyline in three animal models of depression in C57BL\/6\u2009J mice. Psychopharmacology (Berl). 2003;170:94\u2013101.","journal-title":"Psychopharmacology (Berl)"},{"key":"1727_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.biopsych.2004.08.010","volume":"56","author":"BJ Caldarone","year":"2004","unstructured":"Caldarone BJ, Harrist A, Cleary MA, Beech RD, King SL, Picciotto MR. High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biol Psychiatry. 2004;56:657\u201364.","journal-title":"Biol Psychiatry"},{"key":"1727_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pnpbp.2014.06.008","volume":"54","author":"A Wr\u00f3bel","year":"2014","unstructured":"Wr\u00f3bel A, Serefko A, Wla\u017a P, Poleszak E. The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:243\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1727_CR47","first-page":"164943","volume":"2015","author":"G Gupta","year":"2015","unstructured":"Gupta G, Jia Jia T, Yee Woon L, Kumar Chellappan D, Candasamy M, Dua K. Pharmacological evaluation of antidepressant-like effect of Genistein and its combination with Amitriptyline: An acute and chronic study. Adv Pharmacol Sci. 2015;2015:164943.","journal-title":"Adv Pharmacol Sci"},{"key":"1727_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2017.03.026","volume":"215","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Park SD, Lee RM, Lee BH, Choi SH, Hwang SH, et al. Gintonin attenuates depressive-like behaviors associated with alcohol withdrawal in mice. J Affect Disord. 2017;215:23\u20139.","journal-title":"J Affect Disord"},{"key":"1727_CR49","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1471-4159.2008.05357.x","volume":"106","author":"M Tsuchioka","year":"2008","unstructured":"Tsuchioka M, Takebayashi M, Hisaoka K, Maeda N, Nakata Y. Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J Neurochem. 2008;106:244\u201357.","journal-title":"J Neurochem"},{"key":"1727_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1023\/A:1009935116877","volume":"15","author":"R Regenthal","year":"1999","unstructured":"Regenthal R, Krueger M, Koeppel C, Preiss R. Drug levels: therapeutic and toxic serum\/plasma concentrations of common drugs. J Clin Monit Comput. 1999;15:529\u201344.","journal-title":"J Clin Monit Comput"},{"key":"1727_CR51","first-page":"51","volume":"15","author":"Z Fisar","year":"1996","unstructured":"Fisar Z, Krulik R, Fuksov\u00e1 K, Sikora J. Imipramine distribution among red blood cells, plasma and brain tissue. Gen Physiol Biophys. 1996;15:51\u201364.","journal-title":"Gen Physiol Biophys"},{"key":"1727_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1139\/y81-027","volume":"59","author":"PD Hrdina","year":"1981","unstructured":"Hrdina PD, Dubas TC. Brain distribution and kinetics of desipramine in the rat. Can J Physiol Pharmacol. 1981;59:163\u20137.","journal-title":"Can J Physiol Pharmacol"},{"key":"1727_CR53","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell. 2021;184:1299\u2013313.e19.","journal-title":"Cell."},{"key":"1727_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuropharm.2015.12.010","volume":"103","author":"E Castilla-Ortega","year":"2016","unstructured":"Castilla-Ortega E, Pav\u00f3n FJ, S\u00e1nchez-Mar\u00edn L, Estivill-Torr\u00fas G, Pedraza C, Blanco E, et al. Both genetic deletion and pharmacological blockade of lysophosphatidic acid LPA1 receptor results in increased alcohol consumption. Neuropharmacology. 2016;103:92\u2013103.","journal-title":"Neuropharmacology."},{"key":"1727_CR55","doi-asserted-by":"publisher","first-page":"dm035519","DOI":"10.1242\/dmm.035519","volume":"11","author":"RD Moreno-Fern\u00e1ndez","year":"2018","unstructured":"Moreno-Fern\u00e1ndez RD, Nieto-Quero A, G\u00f3mez-Salas FJ, Chun J, Estivill-Torr\u00fas G, Rodr\u00edguez de Fonseca F, et al. Effects of genetic deletion versus pharmacological blockade of the LPA1 receptor on depression-like behaviour and related brain functional activity. Dis Model Mech. 2018;11;dm035519.","journal-title":"Dis Model Mech"},{"key":"1727_CR56","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1124\/mol.64.4.994","volume":"64","author":"H Ohta","year":"2003","unstructured":"Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol. 2003;64:994\u20131005.","journal-title":"Mol Pharmacol"},{"key":"1727_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","volume":"50","author":"JW Choi","year":"2010","unstructured":"Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol. 2010;50:157\u201386.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1727_CR58","doi-asserted-by":"publisher","first-page":"107896","DOI":"10.1016\/j.neuropharm.2019.107896","volume":"164","author":"RD Moreno-Fern\u00e1ndez","year":"2020","unstructured":"Moreno-Fern\u00e1ndez RD, Rosell-Valle C, Bacq A, Zanoletti O, Cifuentes M, P\u00e9rez-Mart\u00edn M, et al. LPA1 receptor and chronic stress: Effects on behaviour and the genes involved in the hippocampal excitatory\/inhibitory balance. Neuropharmacology. 2020;164:107896.","journal-title":"Neuropharmacology."},{"key":"1727_CR59","doi-asserted-by":"publisher","first-page":"110156","DOI":"10.1016\/j.pnpbp.2020.110156","volume":"108","author":"C Rosell-Valle","year":"2021","unstructured":"Rosell-Valle C, Pedraza C, Manuel I, Moreno-Rodr\u00edguez M, Rodr\u00edguez-Puertas R, Castilla-Ortega E, et al. Chronic central modulation of LPA\/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;108:110156.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1727_CR60","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.tibs.2014.10.001","volume":"39","author":"AK Shukla","year":"2014","unstructured":"Shukla AK, Singh G, Ghosh E. Emerging structural insights into biased GPCR signaling. Trends Biochem Sci. 2014;39:594\u2013602.","journal-title":"Trends Biochem Sci"},{"key":"1727_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/acs.chemrev.6b00177","volume":"117","author":"NR Latorraca","year":"2017","unstructured":"Latorraca NR, Venkatakrishnan AJ, Dror RO. GPCR dynamics: Structures in motion. Chem Rev. 2017;117:139\u201355.","journal-title":"Chem Rev"},{"key":"1727_CR62","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1016\/j.molcel.2021.07.033","volume":"81","author":"X Cong","year":"2021","unstructured":"Cong X, Maurel D, D\u00e9m\u00e9n\u00e9 H, Vasiliauskait\u00e9-Brooks I, Hagelberger J, Peysson F, et al. Molecular insights into the biased signaling mechanism of the \u03bc-opioid receptor. Mol Cell. 2021;81:4165\u201375.e6.","journal-title":"Mol Cell"},{"key":"1727_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28417-2","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu S, Paknejad N, Zhu L, Kihara Y, Ray M, Chun J, et al. Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate. Nat Commun. 2022;13:731.","journal-title":"Nat Commun"},{"key":"1727_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33121-2","volume":"13","author":"H Akasaka","year":"2022","unstructured":"Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O. Structure of the active Gi-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist. Nat Commun. 2022;13:5417.","journal-title":"Nat Commun"},{"key":"1727_CR65","first-page":"336","volume":"20","author":"G Garc\u00eda-Rojo","year":"2017","unstructured":"Garc\u00eda-Rojo G, Fresno C, Vilches N, D\u00edaz-V\u00e9liz G, Mora S, Aguayo F, et al. The ROCK inhibitor fasudil prevents chronic restraint stress-induced depressive-like behaviors and dendritic spine loss in Rat Hippocampus. Int J Neuropsychopharmacol. 2017;20:336\u201345.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1727_CR66","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41380-018-0211-5","volume":"25","author":"ME Fox","year":"2020","unstructured":"Fox ME, Chandra R, Menken MS, Larkin EJ, Nam H, Engeln M, et al. Dendritic remodeling of D1 neurons by RhoA\/Rho-kinase mediates depression-like behavior. Mol Psychiatry. 2020;25:1022\u201334.","journal-title":"Mol Psychiatry"},{"key":"1727_CR67","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1124\/mol.64.5.1199","volume":"64","author":"SD Sorensen","year":"2003","unstructured":"Sorensen SD, Nicole O, Peavy RD, Montoya LM, Lee CJ, Murphy TJ, et al. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol Pharmacol. 2003;64:1199\u2013209.","journal-title":"Mol Pharmacol"},{"key":"1727_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.31887\/DCNS.2016.18.4\/ncutler","volume":"18","author":"JJ Sramek","year":"2016","unstructured":"Sramek JJ, Murphy MF, Cutler NR. Sex differences in the psychopharmacological treatment of depression. Dialogues Clin Neurosci. 2016;18:447\u201357.","journal-title":"Dialogues Clin Neurosci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01727-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:55:32Z","timestamp":1705380932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01727-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1038\/s41386-023-01727-9","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}